The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK.
about
The cost-effectiveness of early noninvasive ventilation for ALS patients.Health utility values associated with diabetic retinopathy.Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.Integrating preferences into health status assessment for amyotrophic lateral sclerosis: the ALS Utility Index.Mortality, health, social and economic consequences of amyotrophic lateral sclerosis: a controlled national study.The costs of amyotrophic lateral sclerosis, according to type of care.
P2860
The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
The cost utility analysis of r ...... c lateral sclerosis in the UK.
@en
type
label
The cost utility analysis of r ...... c lateral sclerosis in the UK.
@en
prefLabel
The cost utility analysis of r ...... c lateral sclerosis in the UK.
@en
P1476
The cost utility analysis of r ...... c lateral sclerosis in the UK.
@en
P2093
P304
P356
10.1016/S0022-510X(01)00618-9
P577
2001-10-01T00:00:00Z